Ursa Analytics
Software platform for analyzing and monitoring subvisible particle aggregates in biologic drugs and cell-based medicinal products
- Sector
- Biotech
- Total capital
- $1.2M
- Federal grants
- $955K
- 4 awards · 2018–2024
- Rank in peer group#21 of 28
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- $205K
- 2 awards · Health and Human S
- Rank in Biotech#292 of 4373
- Granted patents
- 0
- 2 pending
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase I · High-Throughput, Label-Free, Unsupervised Image Analysis of CAR-T Cell Data$286K
- Federal contractHealth and Human S · Application Of Artificial Intelligence And Computational Statistics For Biosimilar Product Quality Characterization$25K
- Federal grantHealth and Human S · Phase I · A New Tool to Rapidly Diagnose Sepsis using Flow Imaging Microscopy and Machine Learning$225K
- Federal contractHealth and Human S · Artificial Intelligence Pharmaceutical Imaging Services$180K
- Federal grantHealth and Human S · Phase I · Quantitative Biotherapeutic Particle Characterization via Deep Neural Networks$222K
- Federal grantHealth and Human S · Phase I · Quantitative Biotherapeutic Particle Characterization via Deep Neural Networks$222K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 28 peers
Line = medianBiotech · Software
- Federal grantsBelow median
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 0 granted of 2- PendingSystems And Methods For Applying Machine Learning to Analyze Microcopy Images in High-Throughput SystemsUSPTOApplication 17264690
- PendingSystems And Methods For Applying Machine Learning To Analyze Microcopy Images In High-throughput SystemsUSPTOApplication PCTUS2019044056
Related companies, and why
- ZoneOne PharmaSimilar federal contract value in Biotech · $216K in contracts
- Edesa Biotech, Inc.Similar federal contract value in Biotech · $214K in contracts
- THE TINY CARGO COMPANYSimilar federal contract value in Biotech · $210K in contracts
- Avidity BiosciencesSimilar federal contract value in Biotech · $200K in contracts
- TARGEPEUTICS, INC.Similar federal contract value in Biotech · $200K in contracts
- Celldex TherapeuticsSimilar federal contract value in Biotech · $199K in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .